[1]JournaloftheChemicalSociety,1933,p.1463,1464
[1]CurrentPatentAssignee:CHANGZHOUUNIVERSITY-CN113444020,2021,ALocationinpatent:Paragraph0005-0006;0020-0022;0027-0029;0034-0036
[2]Kukla;Breslin;Gill[JournalofMedicinalChemistry,1990,vol.33,#1,p.223-228]
[3]Lee;Mayer;Wiegrebe;Lauber;Schlunegger[ArchivderPharmazie,1988,vol.321,#5,p.265-272]
[4]Kindler;Peschke[ArchivderPharmazie,1933,vol.271,p.431,435]
[5]Fulton;Robinson[JournaloftheChemicalSociety,1933,p.1463,1464]
[6]Gudaparthi,Vijayalakshmi;Bharathi;Panda,Jagadeesh[AsianJournalofChemistry,2010,vol.22,#7,p.5323-5330]
[7]Uemura,Takeshi;Igarashi,Takuya;Noguchi,Moe;Shibata,Kaname;Chatani,Naoto[ChemistryLetters,2015,vol.44,#5,p.621-623]
[1]Peifer,Christian;Stoiber,Thomas;Unger,Eberhard;Totzke,Frank;Schächtele,Christoph;Marmé,Dieter;Brenk,Ruth;Klebe,Gerhard;Schollmeyer,Dieter;Dannhardt,Gerd[JournalofMedicinalChemistry,2006,vol.49,#4,p.1271-1281]
[2]CurrentPatentAssignee:JOHANNESGUTENBERG-UNIVERSITÄTMAINZ-WO2006/61212,2006,A1Locationinpatent:Page/Pagecolumn15
[1]Bhalerao,DineshS.;Mahajan,UlhasS.;Chaudhari,KiranH.;Akamanchi,KrishnacharyaG.[JournalofOrganicChemistry,2007,vol.72,#2,p.662-665]
Title: The acridone derivative MBLI-87 sensitizes breast cancer resistance protein-expressing xenografts to irinotecan.
Journal: European journal of cancer (Oxford, England : 1990) 20110301
Title: Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
Journal: Bioorganic & medicinal chemistry letters 20101101
Title: Acridone derivatives: design, synthesis, and inhibition of breast cancer resistance protein ABCG2.
Journal: Bioorganic & medicinal chemistry 20070415
